Native T1 and ECV of Noninfarcted Myocardium and Outcome in Patients With Coronary Artery Disease

Journal of the American College of Cardiology

Volumn 71, Issue 7, 2018, Pages 766-778

  Puntmann, Valentina O ^a,b,c   Carr White, Gerry ^b,d   Jabbour, Andrew ^e   Yu, Chung Yao ^e   Gebker, Rolf ^f   Kelle, Sebastian ^f   Rolf, Andreas ^g   Zitzmann, Sabine ^g   Peker, Elif ^a,h   D'Angelo, Tommaso ^a,i   Pathan, Faraz ^a,j   Elen, ^a,k   Valbuena, Silvia ^a,l   Hinojar, Rocio ^a,m   Arendt, Christophe ^a,c   Narula, Jagat ⁿ   Herrmann, Eva ^a   Zeiher, Andreas M ^c   Nagel, Eike ^a,b,c  

^a GOETHE UNIVERSITY   (Germany)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^e St Vincent's Sydney   (Australia)

^f DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^g JUSTUS LIEBIG UNIVERSITY   (Germany)

^h ANKARA UNIVERSITY   (Turkey)

ⁱ UNIVERSITY OF MESSINA   (Italy)

^j UNIVERSITY OF TASMANIA   (Australia)

^k University Jakarta   (Indonesia)

^l HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^m HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁿ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

more..

Author keywords

coronary artery disease; ischemic heart disease; outcome; remodeling; T1 mapping

Indexed keywords

GADOLINIUM;

ACUTE CORONARY SYNDROME; ADULT; ALL CAUSE MORTALITY; ARTICLE; CARDIAC MUSCLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EXTRACELLULAR SPACE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VOLUME; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL PREDICTION; AGED; CINE MAGNETIC RESONANCE IMAGING; CLINICAL TRIAL; DIAGNOSTIC IMAGING; FOLLOW UP; HEART STROKE VOLUME; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; EXTRACELLULAR SPACE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; PROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME;

EID: 85044544236     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.12.020     Document Type: Article

References (44)

1. World Health Organization. Cardiovascular Diseases (CVDs). Available at: http://www.who.int/mediacentre/factsheets/fs317/en. Accessed July 2017.
2. Montalescot, G., Sechtem, U., Achenbach, S., et al. ESC guidelines on the management of stable coronary artery disease. Eur Heart J 34 (2013), 2949–3003.
3. Roffi, M., Patrono, C., Collet, J.-P., et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 37 (2016), 267–315.
4. Ponikowski, P., Voors, A.A., Anker, S.D., et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37 (2016), 2129–2200.
5. Kwong, R.Y., Sattar, H., Wu, H., et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 118 (2008), 1011–1020.
6. Klem, I., Shah, D.J., White, R.D., et al. Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study. Circ Cardiovasc Imaging 4 (2011), 610–619.
7. Kelle, S., Roes, S.D., Klein, C., et al. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol 54 (2009), 1770–1777.
8. Cheong, B.Y.C., Muthupillai, R., Wilson, J.M., et al. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation 120 (2009), 2069–2076.
9. Kwon, D.H., Halley, C.M., Carrigan, T.P., et al. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. J Am Coll Cardiol Img 2 (2009), 34–44.
10. Puntmann, V.O., Peker, E., Chandrashekhar, Y., Nagel, E., T1 mapping in characterizing myocardial disease. Circ Res 119 (2016), 277–299.
11. Rogers, T., Dabir, D., Mahmoud, I., et al. Standardization of T1 measurements with MOLLI in differentiation between health and disease: the ConSept study. J Cardiovasc Magn Reson, 15, 2013, 78.
12. Dabir, D., Child, N., Kalra, A., et al. Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson, 16, 2014, 34.
13. Carrick, D., Haig, C., Rauhalammi, S., et al. Pathophysiology of LV remodeling in survivors of STEMI: inflammation, remote myocardium, and prognosis. J Am Coll Cardiol Img 8 (2015), 779–789.
14. Carberry, J., Carrick, D., Haig, C., et al. Remote zone extracellular volume and left ventricular remodeling in survivors of ST-elevation myocardial infarction. Hypertension 68 (2016), 385–391.
15. Conroy, R.M., Pyörälä K., Fitzgerald, A.P., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24 (2003), 987–1003.
16. Puntmann, V.O., Carr-White, G., Jabbour, A., et al. T1-mapping and outcome in nonischemic cardiomyopathy. J Am Coll Cardiol Img 9 (2016), 40–50.
17. Hussain, S.T., Paul, M., Plein, S., et al. Design and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease. J Cardiovasc Magn Reson, 14, 2012, 65.
18. Hicks, K.A., Tcheng, J.E., Bozkurt, B., et al. 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials. J Am Coll Cardiol 66 (2015), 403–469.
19. Wong, T.C., Piehler, K., Meier, C.G., et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 126 (2012), 1206–1216.
20. Kammerlander, A.A., Marzluf, B.A., Zotter-Tufaro, C., et al. T1 mapping by CMR imaging. J Am Coll Cardiol Img 9 (2016), 14–23.
21. Wong, T.C., Piehler, K.M., Kang, I.A., et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J 35 (2014), 657–664.
22. Aidi El, H., Adams, A., Moons, K.G.M., et al. Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies. J Am Coll Cardiol 63 (2014), 1031–1045.
23. Wagner, A., Mahrholdt, H., Holly, T.A., et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361 (2003), 374–379.
24. McMurray, J.J.V., Adamopoulos, S., Anker, S.D., et al., ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur J Heart Fail 14 (2014), 803–869.
25. Donekal, S., Venkatesh, B.A., Liu, Y.C., et al. Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort: the Multi-Ethnic Study of Atherosclerosis (MESA) study. Circ Cardiovasc Imaging 7 (2014), 292–302.
26. Puntmann, V.O., Arroyo Ucar, E., Hinojar Baydes, R., et al. Aortic stiffness and interstitial myocardial fibrosis by native T1 are independently associated with left ventricular remodeling in patients with dilated cardiomyopathy. Hypertension 64 (2014), 762–768.
27. Ellims, A.H., Shaw, J.A., Stub, D., et al. Diffuse myocardial fibrosis evaluated by post-contrast T1 mapping correlates with left ventricular stiffness. J Am Coll Cardiol 63 (2014), 1112–1118.
28. Hill, J.A., Olson, E.N., Cardiac plasticity. N Engl J Med 358 (2008), 1370–1380.
29. Weber, K.T., Sun, Y., Bhattacharya, S.K., Ahokas, R.A., Gerling, I.C., Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol 10 (2012), 15–26.
30. Van den Borne, S.W., Diez, J., Blankesteijn, W.M., Verjans, J., Hofstra, L., Narula, J., Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 7 (2010), 30–37.
31. Barallobre-Barreiro, J., Didangelos, A., Schoendube, F.A., et al. Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury. Circulation 125 (2012), 789–802.
32. Heymans, S., Corsten, M.F., Verhesen, W., et al. Macrophage microRNA-155 promotes cardiac hypertrophy and failure. Circulation 128 (2013), 1420–1432.
33. Eulalio, A., Mano, M., Dal Ferro, M., et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492 (2012), 376–381.
34. Dimmeler, S., Zeiher, A.M., Netting insights into fibrosis. N Engl J Med 376 (2017), 1475–1477.
35. Heart Outcomes Prevention Evaluation Study Investigators, Yusuf, S., Sleight, P., Pogue, J., Bosch, J., Davies, R., Dagenais, G., Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342 (2000), 145–153.
36. Flather, M.D., Yusuf, S., Kober, L., et al., ACE-Inhibitor Myocardial Infarction Collaborative Group. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet 355 (2000), 1575–1581.
37. Zannad, F., Alla, F., Dousset, B., Perez, A., Pitt, B., Rales Investigators. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the Randomized Aldactone Evaluation Study (RALES). Circulation 102 (2000), 2700–2706.
38. Ridker, P.M., Everett, B.M., Thuren, T., et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377 (2017), 1119–1131.
39. Higgins, D.M., Moon, J.C., Review of T1 mapping methods: comparative effectiveness including reproducibility issues. Curr Cardiovasc Imaging Rep, 7, 2014, 9252.
40. Cameron, D., Vassiliou, V.S., Higgins, D.M., Gatehouse, P.D., Towards accurate and precise T 1 and extracellular volume mapping in the myocardium: a guide to current pitfalls and their solutions. MAGMA 52 (2017), 1–21.
41. Nickander, J., Lundin, M., Abdula, G., et al. Blood correction reduces variability and gender differences in native myocardial T1 values at 1.5 T cardiovascular magnetic resonance: a derivation/validation approach. J Cardiovasc Magn Reson, 19, 2017, 41.
42. Piechnik, S.K., Ferreira, V.M., Lewandowski, A.J., et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson, 15, 2013, 13.
43. Bluemke, D.A., Kawel-Boehm, N., Can a MR imaging scanner accurately measure hematocrit to determine ECV fraction?. J Am Coll Cardiol Img 9 (2016), 64–66.
44. Shaw, L.J., Berman, D.S., Picard, M.H., et al. Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. J Am Coll Cardiol Img 7 (2014), 593–604.